Funding Melanoma Research
National Institutes of Health
In 2006, the Milstein family launched a five-year grant supporting the work of Dr. Steven Rosenberg, Chief of Surgery at the National Cancer Institute at the National Institutes of Health. A clinician and a researcher with a degree in biophysics from Harvard, Dr. Rosenberg has been working on new approaches for treating cancer, based on the body’s immune system. The immune system attacks cancer through lymphatocytes. Dr. Rosenberg has genetically modified patients’ lymphatocytes to better attack the cancer. In so doing, he has developed new, highly effective treatments for melanoma.
That research has resulted, among other things, in the publication of a dozen papers that have made major contributions to the field.
“The support from the Milstein family has had an extraordinary impact on my work. The NIH budget has been flat for six years. Inflation in the costs of medical supplies and equipment has resulted in enormous cuts. The Milsteins’ donations have enabled me to continue research that I couldn’t have done otherwise.”
— Dr. Steven Rosenberg, Chief of Surgery, NCI/NIH